The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer

Clinical trials have shown that epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) did not improve the survival of patients with EGFR-mutated non-small cell lung cancer (NSCLC) because of the high crossover of treatments. Realistically, the role of EGFR-TKIs in NSCLC with mutate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dan, Chen, Xuejing, Qin, Na, Su, Dan, Zhou, Lijuan, Zhang, Quan, Li, Xi, Zhang, Xinyong, Jin, Mulan, Wang, Jinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227705/
https://www.ncbi.nlm.nih.gov/pubmed/28079142
http://dx.doi.org/10.1038/srep40374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227705/
https://www.ncbi.nlm.nih.gov/pubmed/28079142
http://dx.doi.org/10.1038/srep40374

Ejemplares similares